Literature DB >> 22449556

Current applications of human pluripotent stem cells: possibilities and challenges.

Pai-Jiun Ho1, Men-Luh Yen, Shaw-Fang Yet, B Linju Yen.   

Abstract

Stem cells are self-renewable cells with the differentiation capacity to develop into somatic cells with biological functions. This ability to sustain a renewable source of multi- and/or pluripotential differentiation has brought new hope to the field of regenerative medicine in terms of cell therapy and tissue engineering. Moreover, stem cells are invaluable tools as in vitro models for studying diverse fields, from basic scientific questions such as developmental processes and lineage commitment, to practical application including drug screening and testing. The stem cells with widest differentiation potential are pluripotent stem cells (PSCs), which are rare cells with the ability to generate somatic cells from all three germ layers. PSCs are considered the most optimal choice for therapeutic potential of stem cells, bringing new impetus to the field of regenerative medicine. In this article, we discuss the therapeutic potential of human PSCs (hPSCs) including human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs), reviewing the current preclinical and clinical data using these stem cells. We describe the classification of different sources of hPSCs, ongoing research, and currently encountered clinical obstacles of these novel and versatile human stem cells.

Entities:  

Mesh:

Year:  2012        PMID: 22449556     DOI: 10.3727/096368911X627507

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  11 in total

Review 1.  An experimental approach to the generation of human embryonic stem cells equivalents.

Authors:  Katarzyna Skowron; Marcin Tomsia; Piotr Czekaj
Journal:  Mol Biotechnol       Date:  2014-01       Impact factor: 2.695

Review 2.  Livestock models for exploiting the promise of pluripotent stem cells.

Authors:  R Michael Roberts; Ye Yuan; Nicholas Genovese; Toshihiko Ezashi
Journal:  ILAR J       Date:  2015

3.  Pluripotent stem cells in translation: a Food and Drug Administration-National Institutes of Health collaboration.

Authors:  Naomi Kleitman; Mahendra S Rao; David F Owens
Journal:  Stem Cells Transl Med       Date:  2013-06-11       Impact factor: 6.940

4.  A platform for rapid generation of single and multiplexed reporters in human iPSC lines.

Authors:  Ying Pei; Guadalupe Sierra; Renuka Sivapatham; Andrzej Swistowski; Mahendra S Rao; Xianmin Zeng
Journal:  Sci Rep       Date:  2015-03-17       Impact factor: 4.379

5.  Cell therapy in joint disorders.

Authors:  Peter D Counsel; Daniel Bates; Richard Boyd; David A Connell
Journal:  Sports Health       Date:  2015-01       Impact factor: 3.843

6.  ROCK inhibitor is not required for embryoid body formation from singularized human embryonic stem cells.

Authors:  Giuseppe Pettinato; Wendy S Vanden Berg-Foels; Ning Zhang; Xuejun Wen
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

7.  A data analysis framework for biomedical big data: Application on mesoderm differentiation of human pluripotent stem cells.

Authors:  Benjamin Ulfenborg; Alexander Karlsson; Maria Riveiro; Caroline Améen; Karolina Åkesson; Christian X Andersson; Peter Sartipy; Jane Synnergren
Journal:  PLoS One       Date:  2017-06-27       Impact factor: 3.240

8.  Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing.

Authors:  Francesca Pistollato; David Canovas-Jorda; Dimitra Zagoura; Anna Price
Journal:  J Vis Exp       Date:  2017-06-09       Impact factor: 1.355

9.  Sensitive and long-term monitoring of intracellular microRNAs using a non-integrating cytoplasmic RNA vector.

Authors:  Masayuki Sano; Manami Ohtaka; Minoru Iijima; Asako Nakasu; Yoshio Kato; Mahito Nakanishi
Journal:  Sci Rep       Date:  2017-10-04       Impact factor: 4.379

10.  Tributyltin Inhibits Neural Induction of Human Induced Pluripotent Stem Cells.

Authors:  Shigeru Yamada; Yusuke Kubo; Daiju Yamazaki; Yuko Sekino; Yoko Nomura; Sachiko Yoshida; Yasunari Kanda
Journal:  Sci Rep       Date:  2018-08-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.